litlas
Log inCreate account

Philippe Ruszniewski

Active 1993–2025

160
Papers
33,822
Citations
99
h-index
157
i10-index

Citations

Citations per year for Philippe Ruszniewski1984: 2 citations1994: 2 citations1995: 8 citations1996: 4 citations1997: 4 citations1998: 19 citations1999: 21 citations2000: 36 citations2001: 53 citations2002: 53 citations2003: 69 citations2004: 102 citations2005: 115 citations2006: 146 citations2007: 170 citations2008: 209 citations2009: 158 citations2010: 187 citations2011: 235 citations2012: 252 citations2013: 239 citations2014: 253 citations2015: 240 citations2016: 248 citations2017: 290 citations2018: 318 citations2019: 970 citations2020: 1,077 citations2021: 919 citations2022: 658 citations2023: 510 citations2024: 791 citations2025: 305 citations2026: 8 citations1985–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,152 citing papers, 21.8% of this breakdownItaly: 862 citing papers, 8.7% of this breakdownGermany: 814 citing papers, 8.3% of this breakdownFrance: 716 citing papers, 7.3% of this breakdownUnited Kingdom: 634 citing papers, 6.4% of this breakdownChina: 537 citing papers, 5.4% of this breakdownNetherlands: 495 citing papers, 5% of this breakdownJapan: 329 citing papers, 3.3% of this breakdownSwitzerland: 316 citing papers, 3.2% of this breakdownCanada: 291 citing papers, 3% of this breakdownSweden: 287 citing papers, 2.9% of this breakdownSpain: 259 citing papers, 2.6% of this breakdown
0%21.8%Other 22.1%

Institutions

Fields

  • Medicine90.7%
  • Biochemistry, Genetics and Molecular Biology6.9%
  • Neuroscience0.3%
  • Immunology and Microbiology0.3%
  • Engineering0.3%
  • Materials Science0.2%
  • Other1.3%

Topics

  • Neuroendocrine Tumor Research Advances16.9%
  • Pancreatic and Hepatic Oncology Research10.8%
  • Lung Cancer Research Studies10.2%
  • Neuroblastoma Research and Treatments6.3%
  • Pancreatitis Pathology and Treatment5.5%
  • Radiopharmaceutical Chemistry and Applications2.9%
  • Other47.4%

Coauthors

All papers

Open in search
  1. Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors

    Authors: Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning - New England Journal of Medicine 2017 cited by 3,178

  2. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

    Authors: Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła, Alexandria T. Phan, Markus Raderer, Eva Sedláčková, Guillaume Cadiot, Edward M. Wolin, Jaume Capdevila, Lucy Wall, Guido Rindi, Alison Langley, Séverine Martinez, Joëlle Blumberg, Philippe Ruszniewski - New England Journal of Medicine 2014 cited by 1,925

  3. Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

    Authors: Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul, Yung‐Jue Bang, Ivan Borbath, Catherine Lombard‐Bohas, Juan W. Valle, Peter Metrakos, Denis Smith, Aaron I. Vinik, Jen‐Shi Chen, Dieter Hörsch, Pascal Hammel, Bertram Wiedenmann, Eric Van Cutsem, Shem Patyna, Dongrui R. Lu, C. Blanckmeister, Richard C. Chao, Philippe Ruszniewski - New England Journal of Medicine 2011 cited by 2,547

  4. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

    Authors: Johannes Hofland, Massimo Falconi, Emanuel Christ, Justo P. Castaño, Antongiulio Faggiano, Ángela Lamarca, Aurel Perren, Simona Petrucci, Vikas Prasad, Philippe Ruszniewski, Christina Thirlwell, Marie‐Pierre Vullierme, Staffan Welin, Detlef K. Bartsch - Journal of Neuroendocrinology 2023 cited by 228

  5. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial

    Authors: Jonathan Strosberg, Edward M. Wolin, Beth Chasen, Matthew H. Kulke, David Bushnell, Martyn Caplin, Richard P. Baum, Pamela L. Kunz, Timothy J. Hobday, Andrew Hendifar, Kjell Öberg, Maribel Lopera Sierra, Thomas Thevenet, Inés Margalet, Philippe Ruszniewski, Eric P. Krenning, on behalf of the NETTER-1 Study Group - Journal of Clinical Oncology 2018 cited by 389

  6. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

    Authors: Valentina Ambrosini, Jolanta Kunikowska, Eric Baudin, Lisa Bodei, Catherine Bouvier, Jaume Capdevila, Marta Cremonesi, Wouter W. de Herder, Clarisse Dromain, Massimo Falconi, Melpomeni Fani, Stefano Fanti, Rodney J. Hicks, Levent Kabasakal, Gregory Kaltsas, Valerie Lewington, Silvia Minozzi, Michela Cinquini, Kjell Öberg, Wim J.G. Oyen, Dermot O’Toole, Marianne Pavel, Philippe Ruszniewski, Aldo Scarpa, Jonathan Strosberg, Anders Sundin, David Taïeb, Irene Virgolini, Damian Wild, Ken Herrmann, James C. Yao - European Journal of Cancer 2021 cited by 242

  7. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    Authors: M. Caplin, Éric Baudin, Piero Ferollà, Pier Luigi Filosso, Mariano Garcı́a-Yuste, Eric Lim, Kjell Öberg, Giuseppe Pelosi, Aurel Perren, Roberta Rossi, William D. Travis, D.K. Bartsch, Jaume Capdevila, Frederico Costa, Jarosław B. Ćwikła, Wouter W. de Herder, Gianfranco Delle Fave, Barbro Eriksson, Massimo Falconi, Diego Ferone, David J. Gross, Ashley Grossman, Tetsuhide Ito, Robert T. Jensen, Gregory Kaltsas, Fahrettin Keleştimur, Réza Kianmanesh, Ulrich Knigge, Beata Kos‐Kudła, Eric P. Krenning, Emmanuel Mitry, M. Nicolson, Juan Manuel O’Connor, Dermot O’Toole, Ulrich-Frank Pape, Marianne Pavel, John Ramage, Éric Raymond, Guido Rindi, Andrea Rockall, Philippe Ruszniewski, Ramón Salazar, Aldo Scarpa, Eva Sedláčková, Anders Sundin, Christos Toumpanakis, Marie‐Pierre Vullierme, Wolfgang Weber, Bertram Wiedenmann, Zeng Zheng-Pei - Annals of Oncology 2015 cited by 699

  8. Gastroenteropancreatic neuroendocrine tumours

    Authors: Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin - The Lancet Oncology 2008 cited by 1,752

  9. Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN)

    Authors: Vinciane Rebours, Sébastien Gaujoux, Gaspard d’Assignies, Alain Sauvanet, Philippe Ruszniewski, Philippe Lévy, Valérie Paradis, Pierre Bédossa, Anne Couvelard - Clinical Cancer Research 2015 cited by 208

  10. Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results

    Authors: Marianne Pavel, Jarosław B. Ćwikła, Catherine Lombard‐Bohas, Ivan Borbath, Tahir Shah, Ulrich F. Pape, Jaume Capdevila, Francesco Panzuto, Xuan-Mai Truong Thanh, Aude Houchard, Philippe Ruszniewski - European Journal of Cancer 2021 cited by 90

  11. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

    Authors: Gianfranco Delle Fave, Dermot O’Toole, Anders Sundín, Babs G. Taal, Piero Ferollà, John Ramage, Diego Ferone, Tetsuhide Ito, Wolfgang Weber, Z. Zheng-Pei, Wouter W. de Herder, Andreas Pascher, Philippe Ruszniewski, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 cited by 492

  12. MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe d'étude des Tumeurs Endocrines

    Authors: Pierre Goudet, A. Dalac, M. Le Bras, C. Cardot‐Bauters, Patricia Niccoli, N. Lévy-Bohbot, Hélène Du Boullay, Xavier Bertagna, Philippe Ruszniewski, Françoise Borson‐Chazot, Bruno Vergès, Jean‐Louis Sadoul, F. Ménégaux, Antoine Tabarin, Jean‐Marc Kuhn, Pascal D’anella, Olivier Chabre, Sophie Christin-Maître, Guillaume Cadiot, Christine Binquet, Brigitte Delemer - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 194

  13. Putting undergraduate medical students in AI-CDSS designers' shoes: An innovative teaching method to develop digital health critical thinking

    Authors: Rosy Tsopra, Nathan Peiffer-Smadja, Caroline Charlier, Florence Campeotto, Cédric Lemogne, Philippe Ruszniewski, Benoît Vivien, Anita Burgun - International Journal of Medical Informatics, Int. J. Medical Informatics 2022 cited by 39

  14. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

    Authors: John Ramage, Wouter W. de Herder, Gianfranco Delle Fave, Piero Ferollà, Diego Ferone, Tetsuhide Ito, Philippe Ruszniewski, Anders Sundín, Wolfgang Weber, Z. Zheng-Pei, Babs G. Taal, Andreas Pascher, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 cited by 330

  15. Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms

    Authors: James C. Yao, Jonathan Strosberg, Nicola Fazio, Marianne Pavel, Emily K. Bergsland, Philippe Ruszniewski, Daniel M. Halperin, Daneng Li, Salvatore Tafuto, Nitya Raj, Davide Campana, Susumu Hijioka, Markus Raderer, Rosine Guimbaud, Pablo Gajate, Sara Pusceddu, Albert Reising, Evgeny Degtyarev, Mark Shilkrut, Simantini Eddy, Simron Singh - Endocrine Related Cancer 2021 cited by 106

  16. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy

    Authors: Sébastien Gaujoux, Alexandre Cortès, Anne Couvelard, S. Noullet, Laurent Clavel, Vinciane Rebours, Philippe Lévy, Alain Sauvanet, Philippe Ruszniewski, Jacques Belghiti - Surgery 2010 cited by 367

  17. Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study

    Authors: Martyn Caplin, Marianne Pavel, Alexandria T. Phan, Jarosław B. Ćwikła, Eva Sedláčková, Xuan-Mai Truong Thanh, Edward M. Wolin, Philippe Ruszniewski, on behalf of the CLARINET Investigators - Endocrine 2020 cited by 81

  18. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours

    Authors: Stefano Partelli, Detlef K. Bartsch, Jaume Capdevila, Jie Chen, Ulrich Knigge, Bruno Niederle, Els J.�M. Nieveen van Dijkum, Ulrich-Frank Pape, Andreas Pascher, John Ramage, Nick Reed, Philippe Ruszniewski, Jean‐Yves Scoazec, Christos Toumpanakis, Réza Kianmanesh, Massimo Falconi, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 cited by 295

  19. Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

    Authors: Louis de Mestier, Côme Lepage, Éric Baudin, Romain Coriat, F. Courbon, Anne Couvelard, Christine Do Cao, Éric Frampas, Sébastien Gaujoux, Rodica Gincul, Pierre Goudet, Catherine Lombard‐Bohas, Gilles Poncet, Denis Smith, Philippe Ruszniewski, Thierry Lecomte, Olivier Bouché, Thomas Walter, Guillaume Cadiot - Digestive and Liver Disease 2020 cited by 142

  20. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

    Authors: on behalf of the NETTER-1 study group, Jonathan Strosberg, Pamela L. Kunz, Andrew Hendifar, James C. Yao, David Bushnell, Matthew H. Kulke, Richard P. Baum, Martyn Caplin, Philippe Ruszniewski, Ebrahim S. Delpassand, Timothy J. Hobday, Chris Verslype, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaume Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Giovanni Paganelli, Stefano Severi, Michael Morse, David C. Metz, C. Ansquer, F. Courbon, Adil Al‐Nahhas, Eric Baudin, Francesco Giammarile, David Taïeb, Erik Mittra, Edward M. Wolin, Thomas M. O’Dorisio, Rachida Lebtahi, Christophe M. Deroose, Chiara Maria Grana, Lisa Bodei, Kjell Öberg, Berna Polack, Beilei He, Maurizio Mariani, Germo Gericke, Paola Santoro, Jack L. Erion, Laura Ravasi, Eric P. Krenning - European Journal of Nuclear Medicine and Molecular Imaging 2020 cited by 127

  21. MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors

    Authors: Jérôme Cros, Olivia Hentic, Vinciane Rebours, Magaly Zappa, N Gille, Nathalie Théou–Anton, Déwi Vernerey, Frédérique Maire, Patrick Lévy, Pierre Bédossa, Valérie Paradis, Pascal Hammel, Philippe Ruszniewski, Anne Couvelard - Endocrine Related Cancer 2016 cited by 110

  22. Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis

    Authors: Daniel Gaudet, Erik S.G. Stroes, Julie Méthot, Diane Brisson, Karine Tremblay, Sophie J. Bernelot Moens, Giorgio Antonio Iotti, Irene Rastelletti, Diego Ardigò, Deyanira Corzo, Christian Niels Meyer, M.H. Andersen, Philippe Ruszniewski, Mark Deakin, Marco J. Bruno - Human Gene Therapy 2016 cited by 99

  23. Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

    Authors: Sandrine Faivre, Patricia Niccoli, Daniel Castellano, Juan W. Valle, Pascal Hammel, Jean‐Luc Raoul, Aaron I. Vinik, Eric Van Cutsem, Yu Jeong Bang, Seung‐Hoon Lee, Ivan Borbath, Catherine Lombard‐Bohas, Peter Metrakos, Denis Smith, J.-S. Chen, Philippe Ruszniewski, Jean‐François Seitz, Shem Patyna, Dongrui R. Lu, K. Jack Ishak, Éric Raymond - Annals of Oncology 2016 cited by 192

  24. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

    Authors: Kjell Öberg, Anne Couvelard, Gianfranco Delle Fave, David J. Gross, A. Grossman, Robert T. Jensen, Ulrich‐Frank Pape, Aurel Perren, Guido Rindi, Philippe Ruszniewski, Jean‐Yves Scoazec, Staffan Welin, Bertram Wiedenmann, Diego Ferone, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 cited by 173